ReviewImmunoTargets and therapy2014

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?

Diana L Castillo-Carranza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.